维莫非尼治疗BRAF（V600）黑色素瘤的社区经验。 - Suppr

Suppr

超能文献

Community experience of vemurafenib for BRAF(V600) melanoma.

作者信息

Hersey Peter

机构信息

Kolling Institute, and Melanoma Institute of Australia, University of Sydney, NSW 2065, Australia.

出版信息

Lancet Oncol. 2014 Apr;15(4):369-70. doi: 10.1016/S1470-2045(14)70079-8. Epub 2014 Feb 27.

DOI:10.1016/S1470-2045(14)70079-8

PMID:24582506

Abstract

摘要

相似文献

Community experience of vemurafenib for BRAF(V600) melanoma.

Lancet Oncol. 2014 Apr;15(4):369-70. doi: 10.1016/S1470-2045(14)70079-8. Epub 2014 Feb 27.

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27.

[Treatment of metastatic melanoma with BRAF inhibitors].

Hautarzt. 2011 Sep;62(9):696-8. doi: 10.1007/s00105-011-2232-8.

BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.

Melanoma Res. 2014 Aug;24(4):415-8. doi: 10.1097/CMR.0000000000000088.

Cutaneous manifestations of vemurafenib therapy for metastatic melanoma.

J Drugs Dermatol. 2015 May;14(5):509-10.

Overcoming metastatic melanoma with BRAF inhibitors.

Arch Pharm Res. 2011 May;34(5):699-701. doi: 10.1007/s12272-011-0521-5.

Strides in melanoma announced: maximizing value comes next.

J Natl Cancer Inst. 2011 Jul 6;103(13):997-9. doi: 10.1093/jnci/djr254. Epub 2011 Jun 21.

Vemurafenib: a guide to its use in unresectable or metastatic melanoma.

Am J Clin Dermatol. 2013 Feb;14(1):65-9. doi: 10.1007/s40257-012-0007-3.

Vemurafenib for the treatment of BRAF mutant metastatic melanoma.

Future Oncol. 2015;11(4):579-89. doi: 10.2217/fon.14.252.

Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma.

Melanoma Res. 2015 Jun;25(3):246-51. doi: 10.1097/CMR.0000000000000154.

引用本文的文献

Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report.

SAGE Open Med Case Rep. 2019 May 16;7:2050313X19847358. doi: 10.1177/2050313X19847358. eCollection 2019.

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib.

Postepy Dermatol Alergol. 2016 Feb;33(1):52-6. doi: 10.5114/pdia.2015.48045. Epub 2016 Feb 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Community experience of vemurafenib for BRAF(V600) melanoma.

Lancet Oncol. 2014 Apr;15(4):369-70. doi: 10.1016/S1470-2045(14)70079-8. Epub 2014 Feb 27.

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27.

[Treatment of metastatic melanoma with BRAF inhibitors].

Hautarzt. 2011 Sep;62(9):696-8. doi: 10.1007/s00105-011-2232-8.

BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.

Melanoma Res. 2014 Aug;24(4):415-8. doi: 10.1097/CMR.0000000000000088.

Cutaneous manifestations of vemurafenib therapy for metastatic melanoma.

J Drugs Dermatol. 2015 May;14(5):509-10.

Overcoming metastatic melanoma with BRAF inhibitors.

Arch Pharm Res. 2011 May;34(5):699-701. doi: 10.1007/s12272-011-0521-5.

Strides in melanoma announced: maximizing value comes next.

J Natl Cancer Inst. 2011 Jul 6;103(13):997-9. doi: 10.1093/jnci/djr254. Epub 2011 Jun 21.

Vemurafenib: a guide to its use in unresectable or metastatic melanoma.

Am J Clin Dermatol. 2013 Feb;14(1):65-9. doi: 10.1007/s40257-012-0007-3.

Vemurafenib for the treatment of BRAF mutant metastatic melanoma.

Future Oncol. 2015;11(4):579-89. doi: 10.2217/fon.14.252.

Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma.

Melanoma Res. 2015 Jun;25(3):246-51. doi: 10.1097/CMR.0000000000000154.

引用本文的文献

Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report.

SAGE Open Med Case Rep. 2019 May 16;7:2050313X19847358. doi: 10.1177/2050313X19847358. eCollection 2019.

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib.

Postepy Dermatol Alergol. 2016 Feb;33(1):52-6. doi: 10.5114/pdia.2015.48045. Epub 2016 Feb 29.